Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Gilead's Trodelvy stumbles in first-line NSCLC
Despite Trodelvy's flop, analysts remain hopeful that Merck's rival TROP2 ADC, sac-TMT, can succeed in the same first-line NSCLC setting.
Angus Liu
Jun 9, 2026 11:14am
AstraZeneca reprimanded over LinkedIn likes once again
Jun 9, 2026 6:16am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
The Oral GLP-1 Tracker: Oral Wegovy hits 3M prescription milestone
Jun 8, 2026 4:00pm
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
ADA: Lilly's Foundayo pads case against semaglutide in diabetes
Jun 8, 2026 3:42pm
